Chou, R; Turner, JA; Devine, EB; Hansen, RN; Sullivan, SD; Blazina, I; Dana, T; Bougatsos, C; Deyo, RA. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop.. Annals of Internal Medicine. 2015-02-17, 162 (4): 276–86. PMID 25581257. doi:10.7326/M14-2559.
López-Muñoz F, Alamo C. The consolidation of neuroleptic therapy: Janssen, the discovery of haloperidol and its introduction into clinical practice. Brain Research Bulletin. April 2009, 79 (2): 130–141. PMID 19186209. S2CID 7720401. doi:10.1016/j.brainresbull.2009.01.005.
Bockmühl M, Ehrhart G. Über eine neue Klasse von spasmolytisch und analgetisch wirkenden Verbindungen, I [On a new class of spasmolytic and analgesic compounds, I]. Justus Liebigs Annalen der Chemie. 1949, 561 (1): 52–86. doi:10.1002/jlac.19495610107(德语).
Chou, R; Turner, JA; Devine, EB; Hansen, RN; Sullivan, SD; Blazina, I; Dana, T; Bougatsos, C; Deyo, RA. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop.. Annals of Internal Medicine. 2015-02-17, 162 (4): 276–86. PMID 25581257. doi:10.7326/M14-2559.
López-Muñoz F, Alamo C. The consolidation of neuroleptic therapy: Janssen, the discovery of haloperidol and its introduction into clinical practice. Brain Research Bulletin. April 2009, 79 (2): 130–141. PMID 19186209. S2CID 7720401. doi:10.1016/j.brainresbull.2009.01.005.
López-Muñoz F, Alamo C. The consolidation of neuroleptic therapy: Janssen, the discovery of haloperidol and its introduction into clinical practice. Brain Research Bulletin. April 2009, 79 (2): 130–141. PMID 19186209. S2CID 7720401. doi:10.1016/j.brainresbull.2009.01.005.